skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Interrater reliability of the violence risk assessment checklist for youth: a case vignette study
Material Type:
Article
Add to My Research

Interrater reliability of the violence risk assessment checklist for youth: a case vignette study

BMC psychiatry, 2024-04, Vol.24 (1), p.303-303 [Peer Reviewed Journal]

2024. The Author(s). ;COPYRIGHT 2024 BioMed Central Ltd. ;2024. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2024 ;ISSN: 1471-244X ;EISSN: 1471-244X ;DOI: 10.1186/s12888-024-05746-8 ;PMID: 38654194

Full text available

2
[ 18 F]FDG-PET/CT-based risk stratification in women with locally advanced uterine cervical cancer
Material Type:
Article
Add to My Research

[ 18 F]FDG-PET/CT-based risk stratification in women with locally advanced uterine cervical cancer

BMC cancer, 2024-04, Vol.24 (1), p.513-513 [Peer Reviewed Journal]

2024. The Author(s). ;COPYRIGHT 2024 BioMed Central Ltd. ;2024. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2024 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-024-12232-7 ;PMID: 38654241

Full text available

3
Cost-effectiveness of sacituzumab govitecan versus single-agent chemotherapy for metastatic triple-negative breast cancer: a trial-based analysis
Material Type:
Article
Add to My Research

Cost-effectiveness of sacituzumab govitecan versus single-agent chemotherapy for metastatic triple-negative breast cancer: a trial-based analysis

Cost effectiveness and resource allocation, 2024-04, Vol.22 (1), p.32-32 [Peer Reviewed Journal]

2024. The Author(s). ;COPYRIGHT 2024 BioMed Central Ltd. ;2024. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2024 ;ISSN: 1478-7547 ;EISSN: 1478-7547 ;DOI: 10.1186/s12962-024-00539-y ;PMID: 38659013

Full text available

4
Systolic blood pressure status modifies the associations between the triglyceride-glucose index and incident cardiovascular disease: a national cohort study in China
Material Type:
Article
Add to My Research

Systolic blood pressure status modifies the associations between the triglyceride-glucose index and incident cardiovascular disease: a national cohort study in China

Cardiovascular diabetology, 2024-04, Vol.23 (1), p.135-135 [Peer Reviewed Journal]

2024. The Author(s). ;2024. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2024 ;EISSN: 1475-2840 ;DOI: 10.1186/s12933-024-02227-w ;PMID: 38658924

Full text available

5
A pilot study to evaluate the quality of care in oral anticoagulant and antiplatelet use in patients with permanent atrial fibrillation in Irish general practice
Material Type:
Article
Add to My Research

A pilot study to evaluate the quality of care in oral anticoagulant and antiplatelet use in patients with permanent atrial fibrillation in Irish general practice

Primary health care research & development, 2024-04, Vol.25 [Peer Reviewed Journal]

The Author(s), 2024. Published by Cambridge University Press ;The Author(s), 2024. Published by Cambridge University Press. This work is licensed under the Creative Commons Attribution License This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited. (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1463-4236 ;EISSN: 1477-1128 ;DOI: 10.1017/S1463423623000622

Full text available

6
World Organization of National Colleges, Academies and Academic Associations of General Practitioners and Family Physicians (WONCA) Europe position paper on the use of point-of-care ultrasound (POCUS) in primary care
Material Type:
Article
Add to My Research

World Organization of National Colleges, Academies and Academic Associations of General Practitioners and Family Physicians (WONCA) Europe position paper on the use of point-of-care ultrasound (POCUS) in primary care

Primary health care research & development, 2024-04, Vol.25, p.e21-e21 [Peer Reviewed Journal]

The Author(s), 2024. Published by Cambridge University Press ;The Author(s), 2024. Published by Cambridge University Press. This work is licensed under the Creative Commons Attribution License This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited. (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1463-4236 ;EISSN: 1477-1128 ;DOI: 10.1017/S1463423624000112 ;PMID: 38651341

Full text available

7
E‐cigarettes in Nigeria: A scoping review of evidence
Material Type:
Article
Add to My Research

E‐cigarettes in Nigeria: A scoping review of evidence

Health science reports, 2024-04, Vol.7 (4), p.e2074-n/a [Peer Reviewed Journal]

2024 The Authors. published by Wiley Periodicals LLC. ;2024 The Authors. Health Science Reports published by Wiley Periodicals LLC. ;2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2398-8835 ;EISSN: 2398-8835 ;DOI: 10.1002/hsr2.2074 ;PMID: 38660005

Full text available

8
Flow cytometric minimal residual disease measurement accounting for cytogenetics in children with non‐high‐risk acute lymphoblastic leukemia treated according to the ALL‐MB 2008 protocol
Material Type:
Article
Add to My Research

Flow cytometric minimal residual disease measurement accounting for cytogenetics in children with non‐high‐risk acute lymphoblastic leukemia treated according to the ALL‐MB 2008 protocol

Cancer medicine (Malden, MA), 2024-04, Vol.13 (8), p.e7172-n/a [Peer Reviewed Journal]

2024 The Authors. published by John Wiley & Sons Ltd. ;2024 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. ;2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2045-7634 ;EISSN: 2045-7634 ;DOI: 10.1002/cam4.7172 ;PMID: 38651186

Full text available

Searching Remote Databases, Please Wait